Laura Pena-Couso

Laura Pena-Couso

Auto-generated profile, based on publicly available information

Laura Pena-Couso

Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JNJosé A. Nicolás-Ávila
José A. Nicolás-Ávila
LPLaura Pena-Couso
Laura Pena-Couso
PMPura Muñoz-Cánoves
Pura Muñoz-Cánoves
AHAndrés Hidalgo
Andrés Hidalgo
The heart is a never-stopping engine that relies on a formidable pool of mitochondria to generate energy and propel pumping. Because dying cardiomyocytes cannot be replaced, this high metabolic rate creates the challenge of preserving organelle fitness and cell function for life. Here, we provide an immunologist’s perspective on how the heart solves this challenge, which is in part by incorporating macrophages as an integral component of the myocardium. Cardiac macrophages surround cardiomyocytes and capture dysfunctional mitochondria that these cells eject to the milieu, effectively establishing a client cell–support cell interaction. We refer to this heterologous partnership as heterophagy. Notably, this process shares analogies with other biological systems, is essential for proteostasis and metabolic fitness of cardiomyocytes, and unveils a remarkable degree of dependence of the healthy heart on immune cells for everyday function.

16 May 2018 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
LPLaura Pena-Couso
Laura Pena-Couso
JPJosé Perea
José Perea
SMSoraia Melo
Soraia Melo
FMFátima Mercadillo
Fátima Mercadillo
Joana FigueiredoJoana Figueiredo
Joana Figueiredo
MUMiguel Urioste
Miguel Urioste

28 February 2022 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
LPLaura Pena-Couso
Laura Pena-Couso
MEMaría Ercibengoa
María Ercibengoa
FMFátima Mercadillo
Fátima Mercadillo
DGDavid Gómez-Sánchez
David Gómez-Sánchez
LILucía Inglada-Pérez
Lucía Inglada-Pérez
MUMiguel Urioste
Miguel Urioste
Background: The limited knowledge about the PTEN hamartoma tumor syndrome (PHTS) makes its diagnosis a challenging task. We aimed to define the clinical and genetic characteristics of this syndrome in the Spanish population and to identify new genes potentially associated with the disease. Results: We reviewed the clinical data collected through a specific questionnaire in a series of 145 Spanish patients with a phenotypic features compatible with PHTS and performed molecular characterization through several approaches including next generation sequencing and whole exome sequencing (WES). Macrocephaly, mucocutaneous lesions, gastrointestinal polyposis and obesity are prevalent phenotypic features in PHTS and help predict the presence of a PTEN germline variant in our population. We also find that PHTS patients are at risk to develop cancer in childhood or adolescence. Furthermore, we observe a high frequency of variants in exon 1 of PTEN, which are associated with renal cancer and overexpression of KLLN and PTEN. Moreover, WES revealed variants in genes like NEDD4 that merit further research. Conclusions: This study expands previously reported findings in other PHTS population studies and makes new contributions regarding clinical and molecular aspects of PHTS, which are useful for translation to the clinic and for new research lines.

10 April 2026 in Circulation Research
Verified
Journal Article
Closed access
LPLaura Pena-Couso
Laura Pena-Couso
MMMagdalena Makuch
Magdalena Makuch
JNJose Angel Nicolas-Avila
Jose Angel Nicolas-Avila
Mitochondria are essential organelles that transform the energy contained in metabolic substrates into ATP while supporting numerous cellular processes. Traditionally regarded as strictly intracellular, growing evidence now demonstrates that mitochondria and mitochondria-derived components can also be released into the extracellular space, giving rise to extracellular mitochondria. extracellular mitochondria display remarkable heterogeneity, ranging from intact organelles to individual molecular components, free to vesicle-encapsulated structures, and with functional states spanning from severely damaged to metabolically active. Their release is mediated by tightly regulated mechanisms in both living and dying cells, and is influenced by cellular stress, activation state, and pathways that control mitochondrial selection, compartmentalization, trafficking, and extrusion. Extracellular release fulfills multiple functions across the organism, including quality control, modulation of cellular identity, inflammatory signaling, and functional support of recipient cells. In the cardiovascular system, extracellular mitochondria contribute to both homeostasis and disease progression. This review summarizes current knowledge of extracellular mitochondria forms, mechanisms of release, and pathophysiological relevance, and highlights their emerging potential as therapeutic targets in cardiovascular pathophysiology and beyond.

30 November 2025 in bioRxiv
Verified
Preprint
Open access
ABAurora Bernal
Aurora Bernal
AHArslan Hamid
Arslan Hamid
CGCristina Grao-Roldán
Cristina Grao-Roldán
ASAlice Scarpa
Alice Scarpa
ISIria Sánchez
Iria Sánchez
CPCarlos Pérez-Medina
Carlos Pérez-Medina
Background and aims: Lipids play a critical role in atherosclerosis. Low-density lipoprotein (LDL)-cholesterol and certain lipid classes like sphingomyelins are associated with inflammation and poor cardiovascular outcomes. Phosphatidylserine (PS), on the other hand, is a negatively charged anti-inflammatory phospholipid class involved in efferocytosis. In this study, we sought to investigate its anti-atherosclerotic properties through a combination of complementary human lipidomics analyses, in vitro assays and in vivo experiments in Apoe -/- mice. Methods: Human lipidomics studies were performed on the 300OB cohort comprising 300 obese and overweight individuals at risk of cardiovascular disease. In vitro assays were carried out using human monocytes and macrophages, and in vivo experiments included histopathological, immunophenotyping and single-cell transcriptomic analyses. Results: In humans, we identified PS as an anti-inflammatory and atheroprotective biomarker. Hence, we developed a high-density lipoprotein (HDL)-like formulation enriched in PS to exploit its properties in a targeted fashion in mice. In vitro , this formulation potently inhibited inflammatory cytokine production on human myeloid cells. Our in-depth in vivo experiments provided evidence of the formulation’s potent plaque-stabilizing and anti-inflammatory actions. These effects were mediated by a shift in the monocyte/macrophage compartment toward homeostatic/repairing phenotypes. Conclusions: Collectively, our results demonstrate that HDL-associated PS potently suppresses inflammation and atheroprogression, and holds promise as a viable approach to improve immunomodulatory therapies.

4 September 2026 in Science Immunology
Verified
Journal Article
Closed access
LPLaura Pena-Couso
Laura Pena-Couso
JSJon Sicilia
Jon Sicilia
SVSofía Vieto
Sofía Vieto
RSRoberto SILVA-ROJAS
Roberto SILVA-ROJAS
MSMaría Sánchez-Díaz
María Sánchez-Díaz
JNJosé A. Nicolás-Ávila
José A. Nicolás-Ávila
Removal of cellular waste from the extracellular space is fundamental for tissue health. Because the rate of material ejected by parenchymal cells varies across tissues, we searched for mechanisms that couple waste production and removal. Here, we show that the uptake of parenchyma-released mitochondria by macrophages is prominent across organs that rely on oxidative respiration—including heart, skeletal muscle, and brown adipose tissue—and that macrophage numbers closely align with the mitochondrial activity of each of these organs. We found that the mitochondrial activity of myofibers dictates the abundance of macrophages by modulating colony-stimulating factor 1 (CSF1) availability and the number of CSF1-producing fibroblasts in the tissue. Consequently, inhibition of CSF1–CSF1 receptor (CSF1R) signaling depleted macrophages and collapsed the mitochondrial activity of skeletal muscles. We propose that, by coupling macrophage abundance to the mitochondrial activity of their parenchyma, tissues ensure efficient waste disposal and fitness.